Cell No. : Cell Name
RCB2362 : HS-PSS
update : 2022/12/27
|
Comment | Human cell line derived from malignant peripheral nerve sheath tumor. |
Comment from the depositor | |
Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
Remarks | |
Order Form |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
MTA(C-0007p.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Depositor |
Sonobe, Hiroshi
|
Originator |
Sonobe, Hiroshi
|
Year of deposit |
2002
|
Animal |
human
< Mammals
|
Genus |
Homo
|
Species |
sapiens
|
Gender |
Male
|
Tissue |
prostate
|
Disease name |
malignant peripheral nerve sheath tumour (MPNST)
|
Classification |
cancer
|
|
Lifespan |
infinite
|
Morphology |
other
|
Cellosaurus(Expasy) |
CVCL_8717
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
Medium and additives |
|
DMEM (low glucose) + 10% FBS
|
Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
SC frequency |
|
Subculture : once/week, Medium Renewal : 2 times/week
|
Temperature |
|
37
℃
|
CO2 concentration |
|
5
%
|
Freeze medium |
|
Medium + 10% DMSO
|
Freezing method |
|
Slow freezing
|
Mycoplasma |
|
(-)
|
Isozyme |
|
LD, NP
|
STR(human) |
|
OK
|
Images |
deposit info | lot info |
|
|
Reference information |
Reference |
0
|
User's Publication |
3
|
User's Publication |
20115
Huang R, Fujimura A, Nakata E, Takihira S, Inoue H, Yoshikawa S, Hiyama T, Ozaki T, Kamiya A.
Adrenergic signaling promotes the expansion of cancer stem-like cells of malignant peripheral nerve sheath tumors.
Biochem Biophys Res Commun
2021
557:199-205
PubMed ID: 33872989
DOI: 10.1016/j.bbrc.2021.03.172
|
14763
Kolberg M, Bruun J, Murumägi A, Mpindi JP, Bergsland CH, Høland M, Eilertsen IA, Danielsen SA, Kallioniemi O, Lothe RA.
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors
Mol Oncol
2017
11(9):1156-1171
PubMed ID: 28556483
DOI: 10.1002/1878-0261.12086
|
9577
Tanaka T, Kikuchi N, Goto K, Iino M.
Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.
Apoptosis
2016
21:594-608
PubMed ID: 26892009
DOI: 10.1007/s10495-016-1230-9
|